JP2020524141A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020524141A5 JP2020524141A5 JP2019569454A JP2019569454A JP2020524141A5 JP 2020524141 A5 JP2020524141 A5 JP 2020524141A5 JP 2019569454 A JP2019569454 A JP 2019569454A JP 2019569454 A JP2019569454 A JP 2019569454A JP 2020524141 A5 JP2020524141 A5 JP 2020524141A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- composition
- seq
- polypeptide
- elane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022192891A JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
| JP2024119305A JP2024150679A (ja) | 2017-06-15 | 2024-07-25 | がんを処置するための方法および組成物 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762520325P | 2017-06-15 | 2017-06-15 | |
| US62/520,325 | 2017-06-15 | ||
| US201762610711P | 2017-12-27 | 2017-12-27 | |
| US62/610,711 | 2017-12-27 | ||
| PCT/US2018/037800 WO2018232273A1 (en) | 2017-06-15 | 2018-06-15 | Methods and compositions for treating cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022192891A Division JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020524141A JP2020524141A (ja) | 2020-08-13 |
| JP2020524141A5 true JP2020524141A5 (https=) | 2021-09-09 |
| JP7189160B2 JP7189160B2 (ja) | 2022-12-13 |
Family
ID=64659547
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019569454A Active JP7189160B2 (ja) | 2017-06-15 | 2018-06-15 | がんを処置するための方法および組成物 |
| JP2022192891A Active JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
| JP2024119305A Pending JP2024150679A (ja) | 2017-06-15 | 2024-07-25 | がんを処置するための方法および組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022192891A Active JP7529754B2 (ja) | 2017-06-15 | 2022-12-01 | がんを処置するための方法および組成物 |
| JP2024119305A Pending JP2024150679A (ja) | 2017-06-15 | 2024-07-25 | がんを処置するための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12564623B2 (https=) |
| EP (2) | EP4292606B1 (https=) |
| JP (3) | JP7189160B2 (https=) |
| CN (1) | CN111032075A (https=) |
| AU (1) | AU2018285710B2 (https=) |
| CA (1) | CA3066738A1 (https=) |
| DK (1) | DK3638293T5 (https=) |
| ES (2) | ES2962985T3 (https=) |
| WO (1) | WO2018232273A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019403393B2 (en) * | 2018-12-20 | 2026-04-16 | The University Of Chicago | Methods and compositions related to therapeutic peptides for cancer therapy |
| CA3184037A1 (en) * | 2020-08-18 | 2022-02-24 | Onchilles Pharma, Inc. | Modified serine protease proproteins |
| EP4199947A4 (en) * | 2020-08-18 | 2024-10-16 | Onchilles Pharma, Inc. | Modified porcine pancreatic elastase proteins |
| CN112812150A (zh) * | 2021-01-29 | 2021-05-18 | 深圳海创生物科技有限公司 | 一种活性环肽、活性环肽组合物及其在制备具有抗氧化或抗炎作用的产品中的应用 |
| CN113736742B (zh) * | 2021-09-08 | 2023-07-21 | 河南省医药科学研究院 | Prtn3基因作为肿瘤免疫治疗中激活细胞毒性免疫细胞靶点的应用 |
| CN115040642B (zh) * | 2022-06-30 | 2025-03-28 | 德博尔(成都)生物科技有限公司 | 一种胰弹性蛋白酶的新用途 |
| CN118443941A (zh) * | 2024-04-29 | 2024-08-06 | 山东大学齐鲁医院 | 中性粒细胞作为诊疗膀胱癌的靶标的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941763A (en) | 1975-03-28 | 1976-03-02 | American Home Products Corporation | PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH2 and intermediates |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| UA27035C2 (uk) | 1990-08-03 | 2000-02-28 | Вертекс Фармас'Ютікалс Інкорпорейтід | Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму |
| US5698518A (en) * | 1994-03-30 | 1997-12-16 | Oklahoma Medical Research Foundation | Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists |
| AU2003231981A1 (en) * | 2002-03-29 | 2003-10-13 | Incyte Corporation | Protein modification and maintenance molecules |
| CA2500405A1 (en) | 2002-09-30 | 2004-04-15 | Oncotherapy Science, Inc. | Genes and polypeptides relating to human myeloid leukemia |
| JP4408615B2 (ja) | 2002-10-07 | 2010-02-03 | 独立行政法人科学技術振興機構 | 好酸球カチオン性タンパク質を含有する組成物 |
| US8068990B2 (en) | 2003-03-25 | 2011-11-29 | Hologic, Inc. | Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids |
| EP1639090A4 (en) * | 2003-06-09 | 2008-04-16 | Univ Michigan | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER |
| EP1649289B1 (en) | 2003-07-21 | 2008-10-22 | Roche Diagnostics GmbH | Use of proteins proteinase 3 (prn3) and leukocyte elastase inhibitor (ileu) as a marker for colorectal cancer |
| US7432419B2 (en) * | 2004-05-14 | 2008-10-07 | Los Alamos National Security, Llc | Compositions and methods for the treatment of Pierce's disease |
| US20060008891A1 (en) | 2004-06-23 | 2006-01-12 | The Government Of Usa As Repersented By The Secretary, Department Of Health And Human Services | Cathepsin G-related peptides as modulators of formylpeptide receptors (FPR) |
| US20060045881A1 (en) | 2004-08-26 | 2006-03-02 | Board Of Regents, The University Of Texas System | Anti-cancer vaccines |
| US8501449B2 (en) * | 2007-12-04 | 2013-08-06 | Proteon Therapeutics, Inc. | Recombinant elastase proteins and methods of manufacturing and use thereof |
| WO2010009368A2 (en) * | 2008-07-18 | 2010-01-21 | Oragenics, Inc. | Compositions for the detection and treatment of colorectal cancer |
| GB201121070D0 (en) | 2011-12-07 | 2012-01-18 | Isis Innovation | composition for delivery of biotherapeutics |
| WO2016125330A1 (ja) | 2015-02-02 | 2016-08-11 | 原 英彰 | 網膜再生促進薬 |
-
2018
- 2018-06-15 EP EP23191473.0A patent/EP4292606B1/en active Active
- 2018-06-15 EP EP18817894.1A patent/EP3638293B1/en active Active
- 2018-06-15 ES ES18817894T patent/ES2962985T3/es active Active
- 2018-06-15 AU AU2018285710A patent/AU2018285710B2/en active Active
- 2018-06-15 CN CN201880053084.1A patent/CN111032075A/zh active Pending
- 2018-06-15 US US16/621,549 patent/US12564623B2/en active Active
- 2018-06-15 ES ES23191473T patent/ES3055526T3/es active Active
- 2018-06-15 WO PCT/US2018/037800 patent/WO2018232273A1/en not_active Ceased
- 2018-06-15 JP JP2019569454A patent/JP7189160B2/ja active Active
- 2018-06-15 CA CA3066738A patent/CA3066738A1/en active Pending
- 2018-06-15 DK DK18817894.1T patent/DK3638293T5/da active
-
2022
- 2022-12-01 JP JP2022192891A patent/JP7529754B2/ja active Active
-
2024
- 2024-07-25 JP JP2024119305A patent/JP2024150679A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020524141A5 (https=) | ||
| Jiang et al. | Targeted delivery of CXCR4-siRNA by scFv for HER2+ breast cancer therapy | |
| JP2017529059A5 (https=) | ||
| WO2012094653A4 (en) | Compositions and methods for macromolecular drug delivery | |
| US20170260246A1 (en) | Carcinoma homing peptide (chp), its analogs, and methods of using | |
| KR102050621B1 (ko) | Rtrail 변이체 및 이의 모노메틸 오리스타틴 e 접합체 | |
| PL238187B1 (pl) | Koniugaty przeciwciało-ureaza dla celów terapeutycznych | |
| US12377161B2 (en) | TNF-alpha immunoconjugate therapy for the treatment of brain tumors | |
| WO2016186445A1 (ko) | 암 세포 표적용 펩타이드 및 이의 용도 | |
| JP2023145635A (ja) | 免疫調節特性を有するペプチド | |
| Sui et al. | Lipid nanoparticle-mediated targeted mRNA delivery and its application in cancer therapy | |
| Tao et al. | Multivalent assembly of nucleolin-targeted F3 peptide potentiates TRAIL's tumor penetration and antitumor effects | |
| Beswick | Bicycles—An entirely new class of therapeutics | |
| TW201809013A (zh) | 用於藥物遞送之抗體融合蛋白 | |
| CN116832177A (zh) | 干扰趋化素样因子超家族成员6(cmtm6)表达的基因治疗载体的制备和抗肿瘤应用 | |
| CN105985447B (zh) | 一种白蛋白结合型肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 | |
| CN115804853A (zh) | 包含rna分子的组合物及其在制备瘤内注射剂中的用途 | |
| KR20240113641A (ko) | 종양 표적 전달체, mmp 절단서열, 항암펩티드 및 세포투과펩티드를 포함하는 종양 표적화 항체 융합단백질 플랫폼 | |
| Xu et al. | Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels | |
| Maruyama et al. | Albumin Fusion Protein | |
| WO2018219301A1 (zh) | 一种PDGFRβ靶向性肿瘤坏死因子相关凋亡诱导配体变异体及其制备方法和用途 | |
| US20170037091A1 (en) | Sty peptides for inhibition of angiogenesis | |
| JPWO2020132465A5 (https=) | ||
| CN110914421A (zh) | 选择性细胞死亡诱导酶系统 | |
| RU2021108002A (ru) | Пептидные терапевтические препараты для лечения рака и варианты их применения |